• English

    Google Translate Disclaimer

    The Maryland Department of Information Technology (“DoIT”) offers translations of the content through Google Translate. Because Google Translate is an external website, DoIT does not control the quality or accuracy of translated content. All DoIT content is filtered through Google Translate which may result in unexpected and unpredictable degradation of portions of text, images and the general appearance on translated pages. Google Translate may maintain unique privacy and use policies. These policies are not controlled by DoIT and are not associated with DoIT’s privacy and use policies. After selecting a translation option, users will be notified that they are leaving DoIT’s website. Users should consult the original English content on DoIT’s website if there are any questions about the translated content.

    DoIT uses Google Translate to provide language translations of its content. Google Translate is a free, automated service that relies on data and technology to provide its translations. The Google Translate feature is provided for informational purposes only. Translations cannot be guaranteed as exact or without the inclusion of incorrect or inappropriate language. Google Translate is a third-party service and site users will be leaving DoIT to utilize translated content. As such, DoIT does not guarantee and does not accept responsibility for, the accuracy, reliability, or performance of this service nor the limitations provided by this service, such as the inability to translate specific files like PDFs and graphics (e.g. .jpgs, .gifs, etc.).

    DoIT provides Google Translate as an online tool for its users, but DoIT does not directly endorse the website or imply that it is the only solution available to users. All site visitors may choose to use alternate tools for their translation needs. Any individuals or parties that use DoIT content in translated form, whether by Google Translate or by any other translation services, do so at their own risk. DoIT is not liable for any loss or damages arising out of, or issues related to, the use of or reliance on translated content. DoIT assumes no liability for any site visitor’s activities in connection with use of the Google Translate functionality or content.

    The Google Translate service is a means by which DoIT offers translations of content and is meant solely for the convenience of non-English speaking users of the website. The translated content is provided directly and dynamically by Google; DoIT has no direct control over the translated content as it appears using this tool. Therefore, in all contexts, the English content, as directly provided by DoIT is to be held authoritative.

    ​ NEW!


    HPV: Don’t Wait. Vaccinate!

    Increasing First Dose HPV Vaccine for Teens

    A Part 4 Quality Improvement (QI) MOC Project

    ​​​​Registration Flyer
    MOC Summary of Project Online
    HPV MOC Project Instructions_Maryland



    (Human Papillomavirus)

    HPV is a very common and widespread virus, consisting of more than 150 related viruses. Nearly everyone will be infected in their lifetime. In fact, the Centers for Disease Control and Prevention (CDC) estimates that more than 90% of sexually active men and 80% of sexually active women will be infected with at least one type of HPV at some point in their lives. Around one-half of these infections a​re with a high-risk HPV type.1

    • High-risk HPVs can cause cancer. About a dozen high-risk HPV types have been identified.
    • Low-risk HPVs do not cause cancer but can cause skin warts on or around the genitals, anus, mouth, or throat. 

    Most high-risk HPV infections occur without any symptoms, go away within 1 to 2 years, and do not cause cancer. Some HPV infections, however, can persist for many years. Persistent infections with high-risk HPV types can lead to cell changes that, if untreated, may progress to cancer.2

    HPV cancer frequency.png 


    Getting Vaccinated

    HPV print ad_boy.pngThe HPV vaccine can prevent infection with the HPV types that most commonly cause HPV related cancers. 

    The CDC recommends the HPV vaccine be given to 11- to 12-year-old boys and girls so they are protected before ever being exposed to the virus. Research has shown that preteens have a better immune response to the vaccine than those in their late teens and early 20s.3 Vaccination recommendations include:
    • The CDC recommends that 11- to 14-year-olds receive only two doses of HPV vaccine at least six months apart rather than the previously recommended three doses
    • Teens and young adults who start the series later, at ages 15 and older, will continue to need three doses of HPV vaccine to protect against cancer-causing HPV infection.4  
    • In June 2019, the Advisory Committee on Immunization Practices (ACIP) recommended catch-up HPV vaccination for all persons through age 26.5 
    • ACIP did not recommend catch-up vaccination for all adults aged 27 through 45 years, but recognized that some persons who are not adequately vaccinated might be at risk for new HPV infection and might benefit from vaccination in this age range; therefore, ACIP recommended shared clinical decision-making regarding potential HPV vaccination for these persons.6

    Vaccine best at 11-12 years.png 

    Tools and Resources

    ​​Información en español (Information in Spanish)

     For the General Public: 

    For Health Professionals:​​


    Vaccinating against HPV at Age 11-12: Show Me the Evidence

     Vaccinating against HPV at Age 11-12: Show Me the Evidence

    Order 'Fact Sheets for Parents'
    Providers may order the 'Fact Sheet for Parents' (English and Spanish) from MDH in bulk at no cost.  Fact sheets are available in packs of 25. 
     To order, please completely fill out the order form​​​​​​​ with the number of packs your practice requests.  The number of packs ordered will be mailed to you after MDH receives your request.​
    National HPV Vaccination Roundtable Resources
    The National HPV Vaccination Roundtable has created an extensive library of resources that includes educational material for parents, educational materials for health professionals, and various toolkits. Please visit http://hpvroundtable.org/resource-library/​ to learn more. 

    Every health care professional plays an important role in increasing HPV vaccination rates.  Members of the Provider Training Task Group developed a suite of 6 Clinician & System Action Guides to encourage providers, support teams, and health systems to take action today.

    Clinical Guides
    Physicians, Physician Assistants & Nurse Practitioners                        

    Systems Guides


    HPV Vaccination Symposium: Providers Are The Keys
    March 3, 2018

    HPV: Don't Wait. Vaccinate! Increasing First Dose HPV Vaccine for Teens

    HPV DHMH Web Size F1 revised jun17a (2).jpg